Rouen, France-based Robocath, a medical robotics start-up specialising in endovascular procedures, has formerly appointed Pascal Guy as its new chief executive officer.
Guy first joined Robocath in 2015 as a consultant, and has since gradually assumed the role of chief executive. He will now oversee the clinical development and rollout of the R-One robot, as well as work to consolidate the firm’s intellectual property and assets.
He brings over 20 years of medtech experience to the start-up, most recently at US firm Stryker Neurovascular, where he served as international vice president.
Prior to this, Guy was global vice president of sales and marketing for Europe and Japan with the Sorin Group, and worked at Boston Scientific from 1996 to 2007.
Philippe Bencteux, founder and president of Robocath, said: “We are delighted to welcome Pascal Guy in this strategic management position, especially since Robocath is currently at a pivotal moment in its development.
“Thanks to his wealth of experience working with vascular medical devices in some of the leading companies, he will bring to Robocath his strategic management skills, his understanding of the needs of the sector and his up-to-date knowledge of the market.”